Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Zippia finds jobs where you're a top candidate and applies on your behalf.
| Fiscal year / year | Rapid Micro Biosystems revenue |
|---|---|
| 2020 | $16.1M |
| 2021 | $23.2M |
| 2022 | $17.1M |
| 2023 | $22.5M |
| 2024 | $28.1M |
Rate Rapid Micro Biosystems' financial transparency
| Year | Rapid Micro Biosystems growth |
|---|---|
| 2021 | 45%↑ |
| 2022 | -26%↓ |
| 2023 | 31%↑ |
| 2024 | 25%↑ |
Do you work at Rapid Micro Biosystems?
Did Rapid Micro Biosystems meet its revenue projections?
Rapid Micro Biosystems received early financing of $18.6M on 2009-08-06.
| Series | Round size | Date |
|---|---|---|
| Series A | $18.6M | 08/2009 |
| Series Unknown | $6.7M | 09/2010 |
| Debt Financing | $2.5M | 04/2012 |
| Series B | $32.6M | 06/2013 |
| Series Unknown | $6M | 04/2014 |
| Debt Financing | $6M | 03/2015 |
| Series C | $25M | 04/2015 |
| Private Equity | $60M | 05/2018 |
| Private Equity | $120M | 05/2020 |
| Private Equity | $81M | 03/2021 |
| Investors | Security type |
|---|---|
| TVM Capital | Series A |
| Kleiner Perkins | Series A |
| Quaker Partners | Series A |
| VIMAC Milestone Medical Fund | Series A |
| TVM Capital | Series B |
| Longitude Capital | Series B |
| TPG Biotech | Series B |
| Kleiner Perkins | Series B |
| Quaker Partners | Series B |
| TVM Capital | Series Unknown |
| Longitude Capital | Series Unknown |
| Kleiner Perkins | Series Unknown |
| TPG Biotech | Series Unknown |
| Quaker Partners | Series Unknown |
| Hepalink | Series C |
| TVM Capital | Series C |
| Longitude Capital | Series C |
| TPG Biotech | Series C |
| Kleiner Perkins | Series C |
| Quaker Partners | Series C |
| Bain Capital Life Sciences | Private Equity |
| Xeraya Capital | Private Equity |
| Endeavour Vision | Private Equity |
| Ally Bridge Group | Private Equity |
| Bain Capital Life Sciences | Private Equity |
| Xeraya Capital | Private Equity |
| Longitude Capital | Private Equity |
| Asahi Kasei Medical Europe | Private Equity |
| Sunley House Capital Management | Private Equity |
| D1 Capital Partners | Private Equity |
| Adage Capital Management | Private Equity |
| T. Rowe Price | Private Equity |
| CaaS Capital Management | Private Equity |
| BlackRock, Inc. | Private Equity |
Rapid Micro Biosystems's top competitor, Chembio Diagnostics, earned an annual revenue of $49.5B.
Rapid Micro Biosystems's smallest competitor is Quantum Group with revenue of $8.5M last year.
| Company name | Average salary | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| Cepheid | $86,295 | $531.1M | 6,000 | - |
| Terumo Medical | $64,243 | $4.3B | 23,319 | 71 |
| Chembio Diagnostics | $56,310 | $49.5B | 355 | - |
| Biomérieux | $62,385 | - | 6,828 | 82 |
| LGC Biosearch Technologies | $53,497 | $75.0M | 100 | 18 |
| Opti Medical Systems | $62,971 | $27.3M | 105 | - |
| Kensey Nash | $70,107 | $80.4M | 200 | - |
| Terumo Cardiovascular Group | $64,783 | $390.0M | 700 | - |
| Instrumentation Laboratory | $73,298 | $1.0B | 3,000 | 24 |
| Theragenics | $64,277 | $82.6M | 500 | 2 |
Zippia gives an in-depth look into the details of Rapid Micro Biosystems, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Rapid Micro Biosystems. The employee data is based on information from people who have self-reported their past or current employments at Rapid Micro Biosystems. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Rapid Micro Biosystems. The data presented on this page does not represent the view of Rapid Micro Biosystems and its employees or that of Zippia.
Rapid Micro Biosystems may also be known as or be related to RAPID MICRO BIOSYSTEMS, INC., Rapid Micro Biosystems and Rapid Micro Biosystems, Inc.